DOI:
10.1055/s-00000025
Hormone and Metabolic Research
LinksClose Window
References
Zinman B, Wanner C, Lachin JM, Fitchett D, Bluhmki E, Hantel S, Mattheus M, Devins T, Johansen OE, Woerle HJ, Broedl UC, Inzucchi SE. Investigators E-RO.
Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes.
N Engl J Med 2015;
373: 2117-2128
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.